Evidence map›Paper›PMID 41680998›Full record

ArticleHealthcare informatics research2026

Survival Period Prediction in Cervical Cancer Patients Using the Selective Stacking Technique.

Intorn Chanudom, Ekkasit Tharavichitkul, Wimalin Laosiritaworn

Abstract read
In one paragraph

Article in Healthcare informatics research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Intorn ChanudomMaster's Degree Program in Industrial Engineering, Faculty of Engineering, Chiang Mai University, Chiang Mai, Thailand.
Ekkasit TharavichitkulDivision of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Wimalin LaosiritawornDepartment of Industrial Engineering, Faculty of Engineering, Chiang Mai University, Chiang Mai, Thailand.

Funding

Faculty of Engineering, Chiang Mai University
6 · The paper itself

Abstract

objectivesThis study aims to increase the effectiveness of cervical cancer treatment by developing a survival prediction model using an innovative ensemble machine learning approach, namely the selective stacking technique.

methodsPatient data obtained from the Faculty of Medicine, Chiang Mai University, Thailand, were utilized to validate the real-world applicability of the proposed approach. The selective stacking model employed a two-stage machine learning framework in which outputs from base machine learning models were systematically combined through meta-level learning. Importantly, the performance of the proposed model was compared with that reported in previous studies that relied on individual machine learning algorithms as baselines. To provide deeper insight into the predictive mechanisms of the model, local interpretable model-agnostic explanations were applied to assess feature importance and identify the most influential factors contributing to model predictions.

resultsThe classification model developed using the selective stacking technique demonstrated a marked improvement in prediction accuracy, achieving an accuracy of 91.41%. The regression model also showed robust performance, with a root mean square error of 18.92 and an r value of 0.669. Feature importance analysis indicated that side effect status involving surrounding organs emerged as the most influential factor in survival prediction.

conclusionsThe selective stacking model exhibited superior predictive performance compared with the base models, suggesting that this approach offers a promising strategy for cervical cancer survival prediction and may support the development of more personalized treatment planning.

Indexed as

Data InterpretationMachine LearningStatisticalSurvival RateTreatment OutcomeUterine Cervical Neoplasms

Identifiers

PMID41680998
PMCPMC12902129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.